Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Gynaecology Radiotherapy Dear Patient Name TREATMENT SUMMARY You have now completed your initial treatment for cancer. This Treatment Summary provides a summary of your diagnosis, treatment and on-going management plan. It includes information on the symptoms you should be aware of, and who to contact. Your GP will also receive a copy of this summary. Diagnosis: Date of Diagnosis: Summary of Treatment and relevant dates: Treatment Site: Technique: Dose: Gy in fractions Brachytherapy / Phase 2: Gy in fractions Start date: Finish date: Chemotherapy: Drug Cycles: Dose reduction/omission required: Yes / No Reason: Significant events during treatment: : Possible treatment toxicities and / or late effects: Current symptoms Tiredness (fatigue) Bowel symptoms: diarrhoea, abdominal cramps, urgency, increased frequency, pain when opening bowels Bladder symptoms: burning, increased frequency, urgency, incontinence Skin changes: dryness, irritation, hair loss, redness, ulceration Other: Possible future effects of treatment Impaired fertility Premature menopause Sexual consequences: vaginal narrowing, dryness, reduced libido Bowel habit changes Bladder habit changes Bone thinning Leg swelling (lymphoedema) Second cancer Psychological distress Femininity/Body Image Other: Alert Symptoms that require referral back to specialist team: Staging FIGO Stage: PS ECOG Treatment Aim: Fertility referral made: Vaginal Dilators: Discussed Not applicable Hormone replacement therapy (delete as nec): Y/N Clinical Trial: Prescription Charge exemption arranged Yes/No Advise entry onto primary care palliative or supportive care register Yes / No DS 1500 application completed Yes/No Persistent pain in the abdomen/ pelvis Persistent vaginal bleeding/ discharge Persistent rectal bleeding/ blood in urine Abdominal bloating or swelling Excessive urinary frequency which was not present before Others: Persistent breathlessness Persistent cough Constantly feeling tired Unintentional weight loss Loss of appetite Lower limb swelling Secondary Care Ongoing Management Plan: (tests, appointments etc) Year 1 2 3 4 Onward referrals made: (delete as nec) Benefits Advisor Menopause clinic Occupational Therapy Physiotherapy Counselling Psychosexual counsellor Health and Wellness Clinic/ Event Social Service Incontinence team Spiritual support Lymphoedema team Support Group Community Palliative Care Team Genetics referral Other 5 Clinic: Blood tests Scans: Other: Recommended GP actions in addition to GP Cancer Care Review (e.g. ongoing medication, osteoporosis and cardiac screening) Please remove patient from cervical screening program Please prescribe HRT as outlined above Bone density monitoring – Frequency? Please be alert to possibility of new symptoms as a consequence of treatment as outlined above Please be alert to possibility of new symptoms of cancer as outlined above Additional information including issues relating to lifestyle and support needs (delete as necessary): Smoking cessation advice given Diet and weight management Physical activity Alcohol intake Health and Wellbeing Event Date: Summary of information given to the patient about their cancer and future progress: Contact details for referrals or specialist advice: Consultant: Clinical Nurse Specialist: Out of hours: Completing Doctor: Signature: Supporting Documents that may help – Please delete this section before giving to the patient Date: Fatigue Prompt Tool (http://www.londoncanceralliance.nhs.uk/media/122127/lca-hna-fatigue-prompt-sheet-january-2016.pdf) Pain Prompt Tool (http://www.londoncanceralliance.nhs.uk/media/122133/lca-hna-pain-prompt-sheet-january-2016.pdf) Weight Gain prompt tool (http://www.londoncanceralliance.nhs.uk/media/118608/lca-hna-weight-gain-prompt-sheet-january2016-v3.pdf) Sexual Consequences for Women (http://www.londoncanceralliance.nhs.uk/media/118602/lca-hna-sexconsequences-women-prompt-sheet-january-2016.pdf) Lymphoedema Guidelines (http://www.londoncanceralliance.nhs.uk/media/100466/lca-lymphoedema-referral-and-managementguidelines-june-2015.pdf) GP READ CODES FOR COMMON CANCERS (For GP Use only). Other codes available if required. (Note: System codes are case sensitive so always ensure codes are transcribed exactly as below) System 1 Diagnosis: Lung Malignant Tumour Carcinoma of Prostate Malignant tumour of rectum Bowel Intestine Large Bowel Female Malignant Neoplasia Male Malignant Neoplasia Histology/Staging/Grade: Histology Abnormal Tumour grade Dukes/Gleason tumour stage Recurrent tumour Local Tumour Spread Mets from 1° Treatment Palliative Radiotherapy Curative Radiotherapy Chemotherapy Radiotherapy Treatment Aim: Curative procedure Palliative procedure Treatment toxicities/late effects: Osteoporotic # Osteoporosis Infection Ongoing Management Plan Follow up arranged (<1yr) Follow up arranged (>1yr) No FU Referral PRN Referrals made to other services: District Nurse Social Worker Nurse Specialist SALT Actions required by the GP Tumour marker monitoring PSA Osteoporosis monitoring Referral for specialist opinion Advised to apply for free prescriptions Cancer Care Review Palliative Care Review Medication: New medication started by specialist Medication changed by specialist Advice to GP to start medication Advice to GP to stop medication Information to patient: DS1500 form claim Benefits counselling Cancer information offered Cancer diagnosis discussed Aware of diagnosis Unaware of prognosis Carer aware of diagnosis Miscellaneous: On GSF palliative care framework GP OOH service notified Carers details National Cancer Survivorship Initiative December 2010 (5 digit codes) XaOKG X78Y6 XE1vW X78gK X78gN B34.. B35.. 4K14. X7A6m XaOLF XaOR3 X7818 XaFr. 5149. XalpH x71bL Xa851 Xallm XaiL3 Xa1TO XaELC Xa9ua 8H8.. XaL.. 8HA1. 8HAZ. XaBsn XaBsr XaAgq XaBT6 Xalqg Xalqh XalSd Xalst 9D05 Xalyc XalG1 XEOhn 8B316 XaKbF XaJC2 All other systems Version 3 five byte codes (October 2010 release) Diagnosis Malignant neoplasm of bronchus or lung Malignant neoplasm of prostate Malignant neoplasm of Rectum Malignant neoplasm of Colon Malignant neoplasm of female breast Malignant neoplasm of male breast B22z. B46.. B141. B13.. B34.. B35.. Histology/Staging/Grade: Histology Abnormal Tumour staging Gleason grading of prostate Ca Recurrence of tumour 4K14. 4M… 4M0.. 4M6.. Metastatic NOS Treatment Radiotherapy tumour palliation Radiotherapy Chemotherapy BB13. 5149. 7M371 8BAD. Treatment Aim: Curative treatment Palliative treatment 8BJ0. 8BJ1. At risk of osteoporosis Osteoporosis 1409. N330. Ongoing Management Plan Follow up arranged 8H8.. No follow up arranged 8HA.. Referrals made to other services: Refer to District Nurse Refer to Social Worker 8H72. 8H75. Actions required by the GP Tumour marker monitoring PSA Osteoporosis monitoring 8A9.. 43Z2. 66a.. Entitled to free prescription Cancer Care Review Palliative Care Plan Review Medication: Medication given Medication changed 6616. 8BAV. 8CM3. 8BC2. 8B316 Information to patient: DS1500 completed Benefits counselling Cancer information offered Cancer diagnosis discussed 9EB5. 6743. 677H. 8CL0. XaJv2 Xaltp Miscellaneous: On GSF Palliative Care Framework GP OOH service notified 8CM1. 9e0.. 9180. Carer details 9180. XaCDx 6743. XalmL XalpL XaQly XaVzE XaVzA